ALEXION PHARMACEUTICALS, INC. Insider Trading for November 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ALEXION PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ALEXION PHARMACEUTICALS, INC. for November 2014.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 24 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 191.96 | 5,210 | 1,000,112 | 943,676 | 948.9 K to 943.7 K (-0.55 %) |
| Nov 13 2014 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Option Exercise | M | 18.01 | 15,000 | 270,150 | 15,000 | |
| Nov 13 2014 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | S | 195.66 | 15,000 | 2,934,900 | 4,840 | 19.8 K to 4.8 K (-75.60 %) |
| Nov 13 2014 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Buy | M | 18.01 | 15,000 | 270,150 | 19,840 | 4.8 K to 19.8 K (+309.92 %) |
| Nov 10 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Option Exercise | M | 17.98 | 5,693 | 102,360 | 56,832 | |
| Nov 10 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 195.00 | 5,693 | 1,110,135 | 162,770 | 168.5 K to 162.8 K (-3.38 %) |
| Nov 10 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Buy | M | 17.98 | 5,693 | 102,360 | 168,463 | 162.8 K to 168.5 K (+3.50 %) |
| Nov 04 2014 | ALXN | ALEXION PHARMACEUT ... | MACKAY MARTIN | EVP & Global Head o ... | Option Exercise | M | 104.86 | 9,375 | 983,063 | 65,625 | |
| Nov 04 2014 | ALXN | ALEXION PHARMACEUT ... | MACKAY MARTIN | EVP & Global Head o ... | Sell | S | 191.52 | 9,375 | 1,795,500 | 24,426 | 33.8 K to 24.4 K (-27.74 %) |
| Nov 04 2014 | ALXN | ALEXION PHARMACEUT ... | MACKAY MARTIN | EVP & Global Head o ... | Buy | M | 104.86 | 9,375 | 983,063 | 33,801 | 24.4 K to 33.8 K (+38.38 %) |
| Nov 04 2014 | ALXN | ALEXION PHARMACEUT ... | Hallal David | Chief Operating Off ... | Option Exercise | M | 17.65 | 14,336 | 253,030 | 0 | |
| Nov 04 2014 | ALXN | ALEXION PHARMACEUT ... | Hallal David | Chief Operating Off ... | Option Exercise | M | 22.90 | 15,664 | 358,706 | 84,336 | |
| Nov 04 2014 | ALXN | ALEXION PHARMACEUT ... | Hallal David | Chief Operating Off ... | Sell | S | 190.02 | 14,336 | 2,724,127 | 118,616 | 133 K to 118.6 K (-10.78 %) |
| Nov 04 2014 | ALXN | ALEXION PHARMACEUT ... | Hallal David | Chief Operating Off ... | Sell | S | 190.00 | 15,664 | 2,976,160 | 132,952 | 148.6 K to 133 K (-10.54 %) |
| Nov 04 2014 | ALXN | ALEXION PHARMACEUT ... | Hallal David | Chief Operating Off ... | Buy | M | 17.65 | 14,336 | 253,030 | 148,616 | 134.3 K to 148.6 K (+10.68 %) |
| Nov 04 2014 | ALXN | ALEXION PHARMACEUT ... | Hallal David | Chief Operating Off ... | Buy | M | 22.90 | 15,664 | 358,706 | 134,280 | 118.6 K to 134.3 K (+13.21 %) |
| Nov 04 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Option Exercise | M | 17.98 | 30,000 | 539,400 | 62,525 | |
| Nov 04 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Option Exercise | M | 17.98 | 17,475 | 314,201 | 92,525 | |
| Nov 04 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Option Exercise | M | 17.65 | 1,832 | 32,335 | 0 | |
| Nov 04 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 193.36 | 1,089 | 210,569 | 162,770 | 163.9 K to 162.8 K (-0.66 %) |
| Nov 04 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 192.60 | 1,400 | 269,640 | 163,859 | 165.3 K to 163.9 K (-0.85 %) |
| Nov 04 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 191.40 | 8,231 | 1,575,413 | 165,259 | 173.5 K to 165.3 K (-4.74 %) |
| Nov 04 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 190.56 | 19,280 | 3,673,997 | 173,490 | 192.8 K to 173.5 K (-10.00 %) |
| Nov 04 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Buy | M | 17.96 | 30,000 | 538,800 | 192,770 | 162.8 K to 192.8 K (+18.43 %) |
| Nov 04 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 195.18 | 19,307 | 3,768,340 | 162,770 | 182.1 K to 162.8 K (-10.60 %) |
| Nov 04 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Buy | M | 17.96 | 17,475 | 313,851 | 182,077 | 164.6 K to 182.1 K (+10.62 %) |
| Nov 04 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Buy | M | 17.65 | 1,832 | 32,335 | 164,602 | 162.8 K to 164.6 K (+1.13 %) |
| Nov 04 2014 | ALXN | ALEXION PHARMACEUT ... | Islam Saqib | SVP, Chief Strat & ... | Option Exercise | M | 89.23 | 28,125 | 2,509,594 | 46,875 | |
| Nov 04 2014 | ALXN | ALEXION PHARMACEUT ... | Islam Saqib | SVP, Chief Strat & ... | Sell | S | 190.52 | 935 | 178,136 | 27,300 | 28.2 K to 27.3 K (-3.31 %) |
| Nov 04 2014 | ALXN | ALEXION PHARMACEUT ... | Islam Saqib | SVP, Chief Strat & ... | Sell | S | 190.50 | 27,190 | 5,179,695 | 28,235 | 55.4 K to 28.2 K (-49.06 %) |
| Nov 04 2014 | ALXN | ALEXION PHARMACEUT ... | Islam Saqib | SVP, Chief Strat & ... | Buy | M | 89.23 | 28,125 | 2,509,594 | 55,425 | 27.3 K to 55.4 K (+103.02 %) |